1 - 10 of 56 articles
From the birth to the death process, and at many points in between, hypnosis continues to be a valuable adjunctive therapeutic tool.
But it is only an adjunct, emphasized speaker after speaker at the recent meeting of the American Society of Clinical Hypnosis in Denver. With that caveat, the...
Although the use of hypnosis in burn patients can result in pain relief, promotion of healing, and improvement of self-image, the therapy is often underrated and underused.
This was the consensus of many participants in the recent Sixth International Congress on Burns in San Francisco.
That is a choice some terminally ill patients are making, and hypnosis can be the far better alternative, says Wallace L. LaBaw, MD, of Denver, who has treated dozens of such patients over the past decade. He tells of the woman, for example, who "drove her little daughter...
Despite a widespread belief that lentigo maligna melanoma is a radioresistant tumor, therapeutic radiologists at Toronto's Princess Margaret Hospital are recording better than 90% control of this lesion using conventional orthovoltage (140 to 400 kV) techniques.
Reporting this success rate at...
"The X he advantage of human insulin? It may be less immunogenic than animal insulins. It may be the drug of choice for the subpopulation of diabetics that becomes allergic to animal insulins."
So concluded Philip Fireman, MD, of the University of Pittsburgh School of Medicine at the 11th...
They weren't kidding when they called it manned space flight. Only two women, both Russians, have flown in space in the nearly 22 years since the first human launching.
Still, at the National Aeronautics and Space Administration's (NASA) Ames Research Center near San Francisco, women have been...
The first known effort in this country to obtain epidemiologic data about early onset diabetes for an entire state is under way in North Dakota.
So far, says James Brosseau, MD, associate professor of community medicine at the University of North Dakota School of Medicine, Grand Forks, about 300...
To the Editor.—
I wish to express my concern and anxiety over the potential tragedy that might arise from abuse and misuse of isotretinoin (Accutane), which has recently been approved by the Food and Drug Administration for marketing for the treatment of severe recalcitrant cystic acne.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.